| Financial Year |
March 31 2023 |
| Monetary Funds |
3,264,198,623.41 |
| Held-for-trading Financial Assets |
1,193,742,608.46 |
| Notes Receivable |
-- |
| Accounts Receivable |
764,992,328.71 |
| Advances to Suppliers |
100,172,696.68 |
| Other Receivables |
40,644,838.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,650,052,819.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,887,417.26 |
| Total Current Assets |
9,699,035,283.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,536,787,322.12 |
| Investment Properties |
-- |
| Fixed Assetes |
3,488,480,525.90 |
| Under-construction Projects |
170,970,994.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
560,051,381.66 |
| R&D expenses |
1,174,979,185.63 |
| Goodwill |
15,880,377.97 |
| Long-Term Deferred and Prepaid Expenses |
26,080,638.02 |
| Deferred Income Tax Assets |
53,298,595.05 |
| Other Non-Current Assets |
98,599,909.78 |
| Sub-Total of Non-Current Assets |
8,068,616,295.42 |
| Total Assets |
17,767,651,578.68 |
| Short-Term Loans |
934,967,577.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
197,199,164.99 |
| Accounts Payable |
646,189,820.20 |
| Accounts Received In Advance |
72,490,584.92 |
| Employee Compensation Payable |
59,788,445.10 |
| Taxes Payable |
160,630,375.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
158,815,606.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
500,719,154.85 |
| Other Current Liabilities |
836,095.56 |
| Sub-Total of Current Liabilities |
2,808,040,703.52 |
| Long-term Loans |
1,871,952,866.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,349,653.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,139,271,121.42 |
| Total Liabilities |
4,947,311,824.94 |
| Paid-In Capital(Or Share Stock) |
1,499,700,130.00 |
| Capital Surplus |
1,330,073,917.18 |
| Surplus Reserve |
1,525,039,936.38 |
| LESS:Treasury Stock |
105,981,345.62 |
| Undistributed Profits |
8,213,269,030.62 |
| Minority Stockholder's Interest |
261,094,071.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,559,245,682.28 |
| Owner's Equity（Stockholder's Equity） |
12,820,339,753.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,767,651,578.68 |
